Pacific Shuanglin Bio-Pharmacy Co., Ltd. (000403)

Overview

Pacific Shuanglin Bio-pharmacy Co., Ltd., previously known as Southern Shuanglin Bio-pharmacy Co., Ltd., is a significant figure in China's biomedical sector, focusing on the research, development, production, and sales of blood products. Its foundation was laid in 1993, and in April 2021, it underwent a name change to reflect its broadened outlook and commitments. Based in Taiyuan, China, Pacific Shuanglin Bio-pharmacy Co., Ltd. not only concentrates on blood product manufacturing but also actively participates in the investment, consultation, and technological advancement of pharmaceutical and biotechnological development projects. Additionally, it offers electronic product information consultation, underlining its versatile approach to serving the healthcare and biopharmaceutical industries.

Products and Services

• Human Serum Albumin - This crucial product is widely used for treating and managing conditions like burns, shock, and low protein levels due to surgery or liver failure.
• Human Immunoglobulin - Vital for immune system support, human immunoglobulin is used in the treatment of various immune deficiencies and autoimmune disorders.
• Intravenous Human Immunoglobulin (PH4) - A specific formulation of human immunoglobulin designed for intravenous administration, making it crucial for treating conditions requiring rapid immune support.
• Hepatitis B Human Immunoglobulin - Aimed at preventing hepatitis B infection in situations of potential exposure and in patients requiring liver transplantation due to HBV-related liver failure.
• Tetanus Human Immunoglobulin - Provides passive immunity to tetanus as part of emergency treatment following injuries that may lead to tetanus infection.
• Rabies Patient Immunoglobulin - Administered as part of post-exposure prophylaxis to prevent the onset of rabies in individuals exposed to potentially rabid animals.
• Human Coagulation Factor - Essential for the management and treatment of bleeding disorders such as hemophilia, helping in the clotting process.

In addition to these leading products, Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in the broader sphere of the pharmaceutical and biotechnological industry by participating in investment, consultation, and technology promotion projects. This holistic approach towards its business endeavors not only strengthens their product portfolio but also enhances their capabilities in providing comprehensive solutions in the biopharmaceutical domain, including electronic product information consultation services.